The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives
Backed by Semaglutide launches, the company reported 47% quarter-on-quarter revenue growth in Q4 FY26, with EBITDA expanding more than fivefold
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
We are building an AI-native operating system for pharma sales and distribution
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Shashwat Goenka takes over as Vice President of industry body
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
